...OF IND APPLICATION FOR CHM 2101, A NOVEL CDH17 CAR T CELL...
CHM 1101 (CLTX CAR T) is a novel and promising CAR T therapy developed for the treatment of patients with solid tumours. CHM 1101 is currently being studied in a phase1Bclinical trial in recurrent / progress...